Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acids encoding antagonistic CD40 monoclonal antibodies

Nucleic acids encoding antagonistic CD40 monoclonal antibodies

US Patent 11613585 · Granted Mar 28, 2023

Estimated economic value: $211,451,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treatment or prevention of immune responses and inflammatory diseases2025
Methods of treatment or prevention of immune responses and inflammatory diseases2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Antagonistic CD40 monoclonal antibodies and uses thereof2025
Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use2025
Antibodies and antigen binding peptides for factor XIa inhibitors and uses there2024
Compositions monovalent for CD28 binding and methods of use2024
Nucleic acids encoding anti-TREM-1 antibodies2024
Anti-CD40 antibodies and uses thereof2024
Antagonistic CD40 monoclonal antibodies and uses thereof2024
Antagonistic CD40 monoclonal antibodies and uses thereof2024
Anti-TREM-1 antibodies and uses thereof2024